Nishinari Kenji, Krutman Mariana, Aguiar Junior Samuel, Pignataro Bruno Soriano, Yazbek Guilherme, Zottele Bomfim Guilherme Andre, Teivelis Marcelo Passos, Wolosker Nelson
Division of Vascular and Endovascular Surgery, A. C. Camargo Cancer Center, São Paulo, Brazil.
Division of Vascular and Endovascular Surgery, A. C. Camargo Cancer Center, São Paulo, Brazil.
J Vasc Surg. 2015 Jul;62(1):143-9. doi: 10.1016/j.jvs.2015.02.004.
Limb-sparing procedures are currently considered the standard treatment for lower limb soft tissue sarcoma (STS). Surgical excision combined with vascular resection may be necessary to provide an adequate safety margin and to improve the oncologic outcomes. In this scenario, vascular reconstruction is required to preserve limb function. We evaluated the long-term patency and survival outcomes of arterial and venous reconstruction after resecting lower limb STS in the largest single-center case series to date.
Between November 1995 and July 2014, 25 patients with lower limb STS and vascular invasion underwent surgical resection followed by arterial or venous reconstruction. Patients were followed up at regular outpatient visits, at which clinical examinations and duplex ultrasound mapping were performed to assess graft patency.
A total of 44 revascularization procedures were performed. The median follow-up time for the arterial and venous groups combined was 25.2 months (range, 0.26-225.6 months). The 5-year survival probability was 42.1%. The graft occlusion rate was significantly higher after reconstruction with synthetic grafts than after reconstruction with saphenous vein substitutes (P = .02). The occlusion rate was not significantly different between arterial reconstruction and venous reconstruction (P > .05).
Arterial and venous reconstruction is feasible after surgical resection of lower limb STS. Vascular reconstruction provides favorable long-term patency outcomes and low complication rates, allowing limb preservation and disease control in a select group of patients. Vascular reconstruction using venous grafts had a significantly higher patency rate than reconstruction with artificial venous substitutes.
保肢手术目前被认为是下肢软组织肉瘤(STS)的标准治疗方法。手术切除联合血管切除可能是必要的,以提供足够的安全切缘并改善肿瘤学结局。在这种情况下,需要进行血管重建以保留肢体功能。我们在迄今为止最大的单中心病例系列中评估了切除下肢STS后动脉和静脉重建的长期通畅率和生存结局。
1995年11月至2014年7月,25例伴有血管侵犯的下肢STS患者接受了手术切除,随后进行了动脉或静脉重建。患者定期门诊随访,进行临床检查和双功超声检查以评估移植物通畅情况。
共进行了44次血运重建手术。动脉组和静脉组合并后的中位随访时间为25.2个月(范围0.26 - 225.6个月)。5年生存概率为42.1%。人工合成移植物重建后的移植物闭塞率显著高于大隐静脉替代物重建后(P = 0.02)。动脉重建和静脉重建之间的闭塞率无显著差异(P > 0.05)。
下肢STS手术切除后进行动脉和静脉重建是可行的。血管重建提供了良好的长期通畅结局和低并发症发生率,使特定患者群体能够保留肢体并控制疾病。使用静脉移植物进行血管重建的通畅率显著高于人工静脉替代物重建。